REDWOOD CITY, Calif.
Aug. 7, 2013
/PRNewswire/ -- Cardica, Inc. (Nasdaq: CRDC) today announced that
Bernard A. Hausen
, M.D., Ph.D., the company's president and CEO, is scheduled to present a corporate overview and update at Wedbush 2013 Life Sciences Management Access Conference on
Tuesday, August 13
12:45 p.m. Eastern Time
To access the live and subsequently archived webcast of the presentation, go to the Investor Relations section of the company's website at
. Please connect to the website at least 15 minutes prior to the presentation to allow for any necessary software downloads.
Cardica designs and manufactures proprietary stapling and anastomotic devices for cardiac and laparoscopic surgical procedures. Cardica's technology portfolio is intended to minimize operating time and enable minimally-invasive and robot-assisted surgeries. Cardica manufactures and markets its automated anastomosis systems, the C-Port
Distal Anastomosis Systems and PAS-Port
Proximal Anastomosis System for coronary artery bypass graft (CABG) surgery, and has shipped over 46,400 units throughout the world. In addition, Cardica is developing the Cardica
MicroCutter XCHANGE™ 30, a cartridge-based microcutter device with a five-millimeter shaft diameter, and the Cardica
MicroCutter XCHANGE™ 45, a cartridge-based microcutter device with an eight-millimeter shaft. Both MicroCutter devices are designed to be used in a variety of procedures, including bariatric, colorectal, thoracic and general surgery. The Cardica MicroCutter XCHANGE 30 and XCHANGE 45 products require 510(k) review and are not yet commercially available in the U.S.
SOURCE Cardica, Inc.